Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists
Journal of Translational Internal Medicine · 26.06.2025 · 13 (3) · 201-210
DOI: 10.1515/jtim-2025-0026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 20.06.2025. Verfasst von Jianuo Feng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Advanced Diagnostics, Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 1L7, Canada. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
For more than two decades, peripheral administration of GLP-1 or GLP-1 receptor (GLP-1R) agonist (GLP-1RA) curbs appetite and reduce body weight gain in animal models. More importantly, the body weight lowering effect has been effectively observed in clinical practice. There is no doubt that the target sites for GLP-1 or GLP-1RAs to exert those functions are located in the brain. It, however, remains controversy on exactly how these drugs access their targets in the brain. Here, we have discussed literatures on whether peripheral GLP-1 or GLP-1RAs enters the brain via crossing the blood-brain barrier, or the blood cerebrospinal fluid barrier, or given circumventricular organs. We have then commented the view or opinion that peripheral GLP-1RAs may exert their brain functions via organ-organ communications without entering the brain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Advanced Diagnostics, Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 1L7, Canada.
- Department of Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto ON M5S, Canada.
- Banting and Best Diabetes Centre, Temerty Faculty of Medicine, University of Toronto, Toronto ON M5S, Canada.
ORCID-Profile: Tianru Jin
Zitieren
APA
Feng, J., & Jin, T. (2025). Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists. Journal of Translational Internal Medicine, 13(3), 201-210. https://doi.org/10.1515/jtim-2025-0026
Vancouver
Feng J, Jin T. Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists. Journal of Translational Internal Medicine. 2025;13(3):201-210. doi:10.1515/jtim-2025-0026
BibTeX
@article{Feng2025,
author = {Feng, Jianuo and Jin, Tianru},
title = {Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists},
journal = {Journal of Translational Internal Medicine},
year = {2025},
volume = {13},
number = {3},
pages = {201--210},
doi = {10.1515/jtim-2025-0026}
}
EUVIMED